Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Abacavir and Lamivudine Once vs Twice Daily in Thai Children
NCT01656122Phase 3Completed
- Sponsor
- HIV-NAT
- Start
- Jul 2012
- Primary completion
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of abacavir, lamivudine in human immunodeficiency virus infection (HIV), sponsored by HIV-NAT. Started Jul 2012; status: completed.
02
Drugs
abacavirlamivudine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT01656122.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01656122.